Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × fedratinib × Clear all

NCT01420770 2025-03-05

Phase 2 Study of SAR302503 in Patients With Myelofibrosis

Phase 2 Completed

Other hematologic neoplasm

Hematologic Neoplasms

NCT01420783 2025-03-05

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Phase 2 Completed

Other hematologic neoplasm

Hematologic Neoplasms

NCT01523171 2025-03-05

JAKARTA2

Phase 2 Completed

Other hematologic neoplasm

Hematologic Neoplasms